{"id":11047,"date":"2020-05-13T18:11:42","date_gmt":"2020-05-14T02:11:42","guid":{"rendered":"https:\/\/drugpolicy.ca\/?p=11047"},"modified":"2021-04-01T16:54:32","modified_gmt":"2021-04-02T00:54:32","slug":"drug-decriminalization-as-a-necessary-response-to-covid-19","status":"publish","type":"post","link":"https:\/\/drugpolicy.ca\/fr\/drug-decriminalization-as-a-necessary-response-to-covid-19\/","title":{"rendered":"Drug decriminalization as a necessary response to COVID-19"},"content":{"rendered":"\n<p style=\"margin-bottom:-20px; color:#f5f5f5\">drug decriminalization covid 19 drug decriminalization covid 19<\/p>\n\n\n\n<iframe loading=\"lazy\" class=\"scribd_iframe_embed\" title=\"Drug Decriminalization Open Letter to Government _ May 13\" src=\"https:\/\/www.scribd.com\/embeds\/461325384\/content?start_page=1&amp;view_mode=scroll&amp;access_key=key-ZYpZGxsq8UGc0uCFFYkj\" data-auto-height=\"true\" data-aspect-ratio=\"0.7729220222793488\" scrolling=\"no\" width=\"100%\" height=\"600\" frameborder=\"0\"><\/iframe>\n\n\n\n<hr class=\"wp-block-separator has-text-color has-background is-style-dots\" style=\"background-color:#f5f5f5;color:#f5f5f5\"\/>\n\n\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-background\" href=\"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2020\/05\/Drug-Decriminalization-Open-Letter-to-Government-_-May-13.pdf\" style=\"background-color:#c42127\" target=\"_blank\" rel=\"noreferrer noopener\">Download PDF<\/a><\/div>\n<\/div>\n\n\n\n<p style=\"text-align:center; margin-top:10px\"><a href=\"https:\/\/www.surveymonkey.com\/r\/LLLRZJL\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Sign on to the letter<\/strong><\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">&#8220;The COVID-19 pandemic has further exposed stark health inequities and the many structural factors that increase people\u2019s vulnerability to the virus. People who use drugs, and particularly those who are homeless or precariously housed, are more likely to have chronic health issues that will increase their risk of experiencing severe complications should they contract COVID-19. To minimize the risk of transmission and other drug-related health risks, public health officials have urged people who use drugs to continue using harm reduction services, including overdose prevention sites and supervised consumption sites. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Unfortunately, COVID-19 has forced many harm reduction sites across the country to close or reduce the scope of their services, and people who use drugs are navigating new gaps not only in the drug supply chain but also in the resources and supports they rely on, increasing their risk of HIV and hepatitis C (HCV) infection, overdose, and other harms to their health.  Moreover, it is well established that continued police enforcement of simple drug possession laws and the attendant fear of arrest pushes people who use drugs to do so in isolation and compromises their ability to take critical safety precautions. This includes by deterring access to harm reduction services, to which people who use drugs cannot legally travel while in possession of the substances they wish to use there.&#8221;<\/p>\n\n\n\n<div class=\"widget signup-widget mb-5\">\r\n<p class=\"lead\"><strong>\u00cates-vous pr\u00eat(e) \u00e0 aider ?<\/strong><\/p>\r\n<p>Soutenez des politiques sur les drogues bas\u00e9es sur la justice sociale, la compassion et les preuves. Inscrivez-vous \u00e0 notre newsletter pour obtenir des mises \u00e0 jour et d\u00e9couvrez comment vous pouvez agir avec nous.<\/p>\r\n<!-- form.123formbuilder.com script begins here --><script type=\"text\/javascript\" defer=\"defer\" src=\"https:\/\/form.123formbuilder.com\/embed\/6415583.js\" data-role=\"form\" data-default-width=\"650px\"><\/script><!-- form.123formbuilder.com script ends here -->\r\n<\/div>\r\n","protected":false},"excerpt":{"rendered":"<p>The COVID-19 pandemic has further exposed stark health inequities and the many structural factors that increase people\u2019s vulnerability to the virus.<\/p>\n","protected":false},"author":38,"featured_media":11076,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_crdt_document":"","footnotes":""},"categories":[1112],"tags":[],"class_list":["post-11047","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-advocacy"],"acf":[],"mb":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Drug decriminalization as a necessary response to COVID-19 - Canadian Drug Policy Coalition<\/title>\n<meta name=\"description\" content=\"The COVID-19 pandemic has further exposed stark health inequities and the many structural factors that increase people\u2019s vulnerability to the virus.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/drugpolicy.ca\/fr\/drug-decriminalization-as-a-necessary-response-to-covid-19\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Drug decriminalization as a necessary response to COVID-19 - Canadian Drug Policy Coalition\" \/>\n<meta property=\"og:description\" content=\"The COVID-19 pandemic has further exposed stark health inequities and the many structural factors that increase people\u2019s vulnerability to the virus.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/drugpolicy.ca\/fr\/drug-decriminalization-as-a-necessary-response-to-covid-19\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Drug Policy Coalition\" \/>\n<meta property=\"article:published_time\" content=\"2020-05-14T02:11:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-04-02T00:54:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2020\/05\/Decrim-Letter-Thumb-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"650\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Canadian Drug Policy Coalition\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2020\/05\/Decrim-Letter-Thumb-1.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Canadian Drug Policy Coalition\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/drug-decriminalization-as-a-necessary-response-to-covid-19\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/drug-decriminalization-as-a-necessary-response-to-covid-19\\\/\"},\"author\":{\"name\":\"Canadian Drug Policy Coalition\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/c32110f234bdb1f5d978710b6b406a30\"},\"headline\":\"Drug decriminalization as a necessary response to COVID-19\",\"datePublished\":\"2020-05-14T02:11:42+00:00\",\"dateModified\":\"2021-04-02T00:54:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/drug-decriminalization-as-a-necessary-response-to-covid-19\\\/\"},\"wordCount\":242,\"publisher\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/drug-decriminalization-as-a-necessary-response-to-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/20190416_101845-scaled.jpg\",\"articleSection\":[\"Advocacy\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/drug-decriminalization-as-a-necessary-response-to-covid-19\\\/\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/drug-decriminalization-as-a-necessary-response-to-covid-19\\\/\",\"name\":\"Drug decriminalization as a necessary response to COVID-19 - Canadian Drug Policy Coalition\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/drug-decriminalization-as-a-necessary-response-to-covid-19\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/drug-decriminalization-as-a-necessary-response-to-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/20190416_101845-scaled.jpg\",\"datePublished\":\"2020-05-14T02:11:42+00:00\",\"dateModified\":\"2021-04-02T00:54:32+00:00\",\"description\":\"The COVID-19 pandemic has further exposed stark health inequities and the many structural factors that increase people\u2019s vulnerability to the virus.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/drug-decriminalization-as-a-necessary-response-to-covid-19\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/drug-decriminalization-as-a-necessary-response-to-covid-19\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/drug-decriminalization-as-a-necessary-response-to-covid-19\\\/#primaryimage\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/20190416_101845-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/20190416_101845-scaled.jpg\",\"width\":2560,\"height\":1920,\"caption\":\"Two men holding signs\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/drug-decriminalization-as-a-necessary-response-to-covid-19\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Drug decriminalization as a necessary response to COVID-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\",\"name\":\"Canadian Drug Policy Coalition\",\"description\":\"Change policy. Save lives.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\",\"name\":\"Canadian Drug Policy Coalition\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"contentUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"width\":332,\"height\":333,\"caption\":\"Canadian Drug Policy Coalition\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/c32110f234bdb1f5d978710b6b406a30\",\"name\":\"Canadian Drug Policy Coalition\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g\",\"caption\":\"Canadian Drug Policy Coalition\"},\"description\":\"Advocating for public health- and human rights-based drug policy grounded in evidence, compassion, and social justice\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/author\\\/canadian-drug-policy-coalition\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Drug decriminalization as a necessary response to COVID-19 - Canadian Drug Policy Coalition","description":"The COVID-19 pandemic has further exposed stark health inequities and the many structural factors that increase people\u2019s vulnerability to the virus.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/drugpolicy.ca\/fr\/drug-decriminalization-as-a-necessary-response-to-covid-19\/","og_locale":"fr_FR","og_type":"article","og_title":"Drug decriminalization as a necessary response to COVID-19 - Canadian Drug Policy Coalition","og_description":"The COVID-19 pandemic has further exposed stark health inequities and the many structural factors that increase people\u2019s vulnerability to the virus.","og_url":"https:\/\/drugpolicy.ca\/fr\/drug-decriminalization-as-a-necessary-response-to-covid-19\/","og_site_name":"Canadian Drug Policy Coalition","article_published_time":"2020-05-14T02:11:42+00:00","article_modified_time":"2021-04-02T00:54:32+00:00","og_image":[{"width":1000,"height":650,"url":"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2020\/05\/Decrim-Letter-Thumb-1.jpg","type":"image\/jpeg"}],"author":"Canadian Drug Policy Coalition","twitter_card":"summary_large_image","twitter_image":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2020\/05\/Decrim-Letter-Thumb-1.jpg","twitter_misc":{"\u00c9crit par":"Canadian Drug Policy Coalition","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/drugpolicy.ca\/fr\/drug-decriminalization-as-a-necessary-response-to-covid-19\/#article","isPartOf":{"@id":"https:\/\/drugpolicy.ca\/fr\/drug-decriminalization-as-a-necessary-response-to-covid-19\/"},"author":{"name":"Canadian Drug Policy Coalition","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/person\/c32110f234bdb1f5d978710b6b406a30"},"headline":"Drug decriminalization as a necessary response to COVID-19","datePublished":"2020-05-14T02:11:42+00:00","dateModified":"2021-04-02T00:54:32+00:00","mainEntityOfPage":{"@id":"https:\/\/drugpolicy.ca\/fr\/drug-decriminalization-as-a-necessary-response-to-covid-19\/"},"wordCount":242,"publisher":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization"},"image":{"@id":"https:\/\/drugpolicy.ca\/fr\/drug-decriminalization-as-a-necessary-response-to-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2020\/05\/20190416_101845-scaled.jpg","articleSection":["Advocacy"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/drugpolicy.ca\/fr\/drug-decriminalization-as-a-necessary-response-to-covid-19\/","url":"https:\/\/drugpolicy.ca\/fr\/drug-decriminalization-as-a-necessary-response-to-covid-19\/","name":"Drug decriminalization as a necessary response to COVID-19 - Canadian Drug Policy Coalition","isPartOf":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/drugpolicy.ca\/fr\/drug-decriminalization-as-a-necessary-response-to-covid-19\/#primaryimage"},"image":{"@id":"https:\/\/drugpolicy.ca\/fr\/drug-decriminalization-as-a-necessary-response-to-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2020\/05\/20190416_101845-scaled.jpg","datePublished":"2020-05-14T02:11:42+00:00","dateModified":"2021-04-02T00:54:32+00:00","description":"The COVID-19 pandemic has further exposed stark health inequities and the many structural factors that increase people\u2019s vulnerability to the virus.","breadcrumb":{"@id":"https:\/\/drugpolicy.ca\/fr\/drug-decriminalization-as-a-necessary-response-to-covid-19\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/drugpolicy.ca\/fr\/drug-decriminalization-as-a-necessary-response-to-covid-19\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/drugpolicy.ca\/fr\/drug-decriminalization-as-a-necessary-response-to-covid-19\/#primaryimage","url":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2020\/05\/20190416_101845-scaled.jpg","contentUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2020\/05\/20190416_101845-scaled.jpg","width":2560,"height":1920,"caption":"Two men holding signs"},{"@type":"BreadcrumbList","@id":"https:\/\/drugpolicy.ca\/fr\/drug-decriminalization-as-a-necessary-response-to-covid-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.drugpolicy.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Drug decriminalization as a necessary response to COVID-19"}]},{"@type":"WebSite","@id":"https:\/\/www.drugpolicy.ca\/fr\/#website","url":"https:\/\/www.drugpolicy.ca\/fr\/","name":"Canadian Drug Policy Coalition","description":"Change policy. Save lives.","publisher":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.drugpolicy.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization","name":"Canadian Drug Policy Coalition","url":"https:\/\/www.drugpolicy.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","contentUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","width":332,"height":333,"caption":"Canadian Drug Policy Coalition"},"image":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/person\/c32110f234bdb1f5d978710b6b406a30","name":"Canadian Drug Policy Coalition","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g","caption":"Canadian Drug Policy Coalition"},"description":"Advocating for public health- and human rights-based drug policy grounded in evidence, compassion, and social justice","url":"https:\/\/drugpolicy.ca\/fr\/author\/canadian-drug-policy-coalition\/"}]}},"mfb_rest_fields":["title","yoast_head","yoast_head_json"],"_links":{"self":[{"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/11047","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/comments?post=11047"}],"version-history":[{"count":31,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/11047\/revisions"}],"predecessor-version":[{"id":15002,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/11047\/revisions\/15002"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/media\/11076"}],"wp:attachment":[{"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/media?parent=11047"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/categories?post=11047"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/tags?post=11047"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}